Gregory H. Bailey
Independent DirectorDr. Gregory H. Bailey, M.D. M.B.A., also known as Greg, serves as an Independent Director of Serina Therapeutics, Inc. since March 26, 2024 and is its Co-Chairman of the Board of Directors from March 2026. He serves as a Director at BYOMass Inc. He serves as Independent Director at Biohaven Ltd. since September 2022. He serves as Non-Executive Director at SalvaRx Group plc. He had been Chairman of AgeX Therapeutics, Inc. since October 2018 until May 2022 and serves as its an Independent Director since August 2018. He serves as Chairman of SalvaRx Group plc (formerly known as SalvaRx Limited). He serves as a Member of Scientific Advisory Board at NCL Technology Ventures Ltd. He is the Chief Executive Officer of Juvenescence AI. He serves as Non-Executive Director at Manx Financial Group PLC since March 2018. He is a Co-Founder, Partner and Managing Partner of Mediqventures since January 2014. Dr. Bailey is a Co-Founder of Portage Pharma Limited (PPL) and serves as its Chief Business Officer. He is a Co-Founder and Director at Juvenescence Limited and served as its Chief Executive Officer since October 2017 until January 16, 2023. He serves as Executive Chairman of Juvenescence Ltd. since January 16, 2023. He is a Co-Founder of Ascent Healthcare Solutions, VirnetX Inc. iWin, Inc. and Duramedic Inc. He serves as an Executive Officer at several publicly traded companies and founded companies in pharmaceuticals, medical device and health care services. He has experience in finance, corporate management, pharmaceuticals, medical devices and general healthcare practices. He served at Verdant Ventures Advisors, LLC. He founded Palantir Group Inc. He was a Founder of SalvaRx Group Plc. He served as a Managing Partner at Palantir Group, Inc. since April 2002 and serves as its Director. He served as the President and Chief Executive Officer of PlayLink Inc. He was a Financier of Medivation Inc. He served as Vice President of Technology at Firstgold Corp. He served as a Co-Chief Executive Officer of iWin, Inc. He served as the Managing Director and co-Head of Life Sciences at MDB Capital Group Limited Liability Company from May 2004 to December 2006. He served as Life Sciences Analyst at Participating Capital. After as a practicing physician specializing in emergency medicine, he spent as an Entrepreneur, Executive and Financier in the health care sector. From June 2002 to June 2003, he served as Managing Director of Gilford Securities, Inc. From 1998 to June 2002, he served as Managing Director of Knightsford Bank Corp. Prior posts within the financial services industry included Senior Managing Director positions at Viscogliosi Brothers, the LXV Prosperity Fund. He founded ABN Private Equity Fund and served as its General Manager. In 1995, he co-founded EuroAmerican Mercantile Bancorp (EuroAmerican), a London based international bank. He served as a Managing Partner of EuroAmerican. He co-founded V-Fund Investments, Ltd. and served as its Chief Executive Officer and President. He has built a career as a Physician, an entrepreneur and as an Investment Banker. He served Lead Director of Alpha Compute Corp (formerly known as AlphaTON Capital Corp.) (formerly known as Portage Biotech Inc.) since August 2022 until September 25, 2025. He served as an Independent Chairman of the Board at Portage Biotech Inc until August 2022. and its an Independent Director since June 4, 2013. He is a Director of Portage Pharmaceuticals Limited since June 2013. He served as the Chairman at Bontan Corporation, Inc. He had been Independent Non-Executive Director of Biohaven Pharmaceutical Holding Company Ltd. since January 2014 until October 03, 2022. He has been Director at Prism Technologies LLC since 2012. He has been a Director at Sentien Biotechnologies, Inc. since August 2015. He serves as a Director of iWin, Inc. Orion Acquisition Corp. II, Trojan Technologies USA, LLC and Secure Axcess, LLC. He served on multiple public and private company boards of Directors, such as Ascent Healthcare Solutions, VirnetX Inc. DuraMedic Inc. and MediqVentures Ltd. He served as an Independent Director of Bontan Corporation, Inc. since June 4, 2013. He served as a Director at Regent Pacific Group Limited (also known as Plethora Solutions Holdings PLC) since September 4, 2013. He served as a Non-Executive Director of 3Legs Resources plc since June 9, 2015. He served on the Board of Directors of 16 public companies. He served as an Independent Director of Medivation, Inc. from 2005 to December 2012. He served as a Member of Corporate Advisory Board at Provectus Biopharmaceuticals, Inc. He served as a Director of Sportan United Industries Inc. since April 2006. He served as a Director of Opexa Therapeutics, Inc. (formerly Pharmafrontiers Corp) from April 17, 2006 to December 10, 2008. He practiced for certain as an emergency room Physician. He is Director of BioHaven Inc. He extensive experience in investment banking and has founded several companies along with comprehensive experience in healthcare, finance and medicine. He received his medical degree from the University of Western Ontario and an MBA at Carnegie Mellon University's Tepper School of Business.
Positions
- Company NameBiohaven Ltd.Stock CodeBHVNPositionIndependent DirectorColleagues
- VCVladimir CoricChairman & CEO
- MBMatthew ButenChief Financial Officer
- KGKimberly GentileSenior Vice President of Clinical Operations
- BDBruce D. CarChief Innovation Officer
- DYDeb YoungSenior Director of Regulatory Affairs & Operations
- DGDouglas GrayCorporate Secretary & Director
- MTMichael Thomas HeffernanLead Independent Director
- GHGregory H. BaileyIndependent Director
- JWJohn Winston ChildsIndependent Director
- Company NameSerina Therapeutics, Inc.Stock CodeSERPositionIndependent Co-Chairman of the Board of DirectorsColleagues
- BGBalkrishan GillExecutive Co-Chairman of the Board
- SASteven A. LedgerCEO & Director
- JMJ. Milton HarrisCo-Founder, Director Emeritus & Chair of Scientific Advisory Board
- STSrini TenjarlaChief Technical Operations Officer
- RWRandall W. MoreadithChief Development Officer
- KJKaren J. WilsonIndependent Director
